159 related articles for article (PubMed ID: 26691592)
1. Cytotoxicity of 5-fluorouracil-loaded pH-sensitive liposomal nanoparticles in colorectal cancer cell lines.
Udofot O; Affram K; Israel B; Agyare E
Integr Cancer Sci Ther; 2015; 2(5):245-252. PubMed ID: 26691592
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic, biodistribution and therapeutic efficacy of 5-fluorouracil-loaded pH-sensitive PEGylated liposomal nanoparticles in HCT-116 tumor bearing mouse.
Udofot O; Affram K; Smith T; Tshabe B; Krishnan S; Sachdeva M; Agyare E
J Nat Sci; 2016; 2(1):. PubMed ID: 27200415
[TBL] [Abstract][Full Text] [Related]
3. Application of smart solid lipid nanoparticles to enhance the efficacy of 5-fluorouracil in the treatment of colorectal cancer.
Smith T; Affram K; Nottingham EL; Han B; Amissah F; Krishnan S; Trevino J; Agyare E
Sci Rep; 2020 Oct; 10(1):16989. PubMed ID: 33046724
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Anticancer Activity of Zhubech, a New 5-FU Analog Liposomal Formulation, against Pancreatic Cancer.
Ndemazie NB; Bulusu R; Zhu XY; Frimpong EK; Inkoom A; Okoro J; Ebesoh D; Rogers S; Han B; Agyare E
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901721
[TBL] [Abstract][Full Text] [Related]
5. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles.
Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB
Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428
[TBL] [Abstract][Full Text] [Related]
6. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
7. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells.
Sharma A; Kaur A; Jain UK; Chandra R; Madan J
Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329
[TBL] [Abstract][Full Text] [Related]
8. Mannose Conjugated Starch Nanoparticles for Preferential Targeting of Liver Cancer.
Jain AK; Sahu H; Mishra K; Thareja S
Curr Drug Deliv; 2021; 18(3):369-380. PubMed ID: 32885751
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells.
Mansoori B; Mohammadi A; Abedi-Gaballu F; Abbaspour S; Ghasabi M; Yekta R; Shirjang S; Dehghan G; Hamblin MR; Baradaran B
J Cell Physiol; 2020 Oct; 235(10):6817-6830. PubMed ID: 31989649
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk of low density lipoprotein and liposome as a paradigm for targeting of 5-fluorouracil into hepatic cells: cytotoxicity and liver deposition.
Alanazi SA; Harisa GI; Badran MM; Alanazi FK; Elzayat E; Alomrani AH; Al Meanazel OT; Al Meanazel AT
Bioengineered; 2021 Dec; 12(1):914-926. PubMed ID: 33678142
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies.
Alhowyan AA; Kalam MA; Iqbal M; Raish M; El-Toni AM; Alkholief M; Almomen AA; Alshamsan A
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770926
[TBL] [Abstract][Full Text] [Related]
12. Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Thomas AM; Kapanen AI; Hare JI; Ramsay E; Edwards K; Karlsson G; Bally MB
J Control Release; 2011 Mar; 150(2):212-9. PubMed ID: 21094191
[TBL] [Abstract][Full Text] [Related]
13. In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment.
Azarifar Z; Amini R; Tanzadehpanah H; Afshar S; Najafi R
Mol Biol Rep; 2023 Dec; 50(12):10047-10059. PubMed ID: 37902908
[TBL] [Abstract][Full Text] [Related]
14. Surface modified nanoliposome formulations provide sustained release for 5-FU and increase cytotoxicity on A431 cell line.
Yaman Ü; Aslan M; Ozturk S; Ulubayram K; Eroğlu İ
Pharm Dev Technol; 2020 Dec; 25(10):1192-1203. PubMed ID: 32729757
[TBL] [Abstract][Full Text] [Related]
15. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil in vesicular phospholipid gels for anticancer treatment: entrapment and release properties.
Kaiser N; Kimpfler A; Massing U; Burger AM; Fiebig HH; Brandl M; Schubert R
Int J Pharm; 2003 Apr; 256(1-2):123-31. PubMed ID: 12695018
[TBL] [Abstract][Full Text] [Related]
17. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
18. Nanoemulsion carriers of porous γ-alumina modified by polyvinylpyrrolidone and carboxymethyl cellulose for pH-sensitive delivery of 5-fluorouracil.
Shamsabadipour A; Pourmadadi M; Rashedi H; Yazdian F; Navaei-Nigjeh M
Int J Biol Macromol; 2023 Apr; 233():123621. PubMed ID: 36773864
[TBL] [Abstract][Full Text] [Related]
19. The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer.
Alomrani A; Badran M; Harisa GI; ALshehry M; Alhariri M; Alshamsan A; Alkholief M
Saudi Pharm J; 2019 Jul; 27(5):603-611. PubMed ID: 31297013
[TBL] [Abstract][Full Text] [Related]
20. Development of α-tocopherol surface-modified targeted delivery of 5-fluorouracil-loaded poly-D, L-lactic-co-glycolic acid nanoparticles against oral squamous cell carcinoma.
Srivastava S; Gupta S; Mohammad S; Ahmad I
J Cancer Res Ther; 2019; 15(3):480-490. PubMed ID: 31169208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
